CompletedPhase 3NCT06744777

The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever

Studying Dengue fever

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Khyber Medical University Peshawar
Principal Investigator
Said Amin, MBBS,FCPS
Department of Medicine Hayatabad Medical Complex Peshawar
Intervention
Ribavirin(drug)
Enrollment
284 enrolled
Eligibility
18 years · All sexes
Timeline
2024 – 2025

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06744777 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever →

← Back to all trials